| ABOUT US |  |
| FIND US | |
DI BELLA METHOD > DOCUMENTATION INDEX > SCIENTIFIC WORKS
SCIENTIFIC WORKS
Melatonin, sleep disturbance and cancer risk.
(06/05/2011)
Detail
Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells.
(06/05/2011)
Detail
Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.
(06/05/2011)
Detail
Melatonin prevents the development of hyperplastic urothelium induced by repeated doses of cyclophosphamide.
(06/05/2011)
Detail
Light-at-night, circadian disruption and breast cancer: assessment of existing evidence.
(06/05/2011)
Detail
Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines.
(06/05/2011)
Detail
Measuring serum melatonin in epidemiologic studies.
(06/05/2011)
Detail
Melatonin and metformin inhibit skin carcinogenesis induced by benz(a)pyrene in mice
(06/05/2011)
Detail
Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.
(06/05/2011)
Detail
Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cells
(06/05/2011)
Detail
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
(06/05/2011)
Detail
Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.
(06/05/2011)
Detail
Beneficial effects of melatonin on nicotine-induced vasculopathy.
(06/05/2011)
Detail
Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
(06/05/2011)
Detail
Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration.
(06/05/2011)
Detail
